应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06185 康希诺生物
清明节翌日休市 04-02 16:08:21
33.040
-0.780
-2.31%
最高
33.660
最低
32.420
成交量
105.28万
今开
33.540
昨收
33.820
日振幅
3.67%
总市值
81.62亿
流通市值
43.83亿
总股本
2.47亿
成交额
3,461万
换手率
0.79%
流通股本
1.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康希诺生物更新3月股份变动月报表,股本维持稳定
公告速递 · 04-02
康希诺生物更新3月股份变动月报表,股本维持稳定
异动解读 | 康希诺生物盘中大涨9.68%,业绩扭亏为盈及流脑疫苗收入增长提振股价
异动解读 · 04-01
异动解读 | 康希诺生物盘中大涨9.68%,业绩扭亏为盈及流脑疫苗收入增长提振股价
港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长 全年纯利实现扭亏为盈
智通财经 · 04-01
港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长 全年纯利实现扭亏为盈
康希诺生物(06185)公布2025年业绩 实现收入约10.59亿元 同比增长28.43%
智通财经 · 03-31
康希诺生物(06185)公布2025年业绩 实现收入约10.59亿元 同比增长28.43%
每日卖空追踪 | 康希诺生物 03月11日卖空量成交5800股,卖空比例为1.68%
市场透视 · 03-11
每日卖空追踪 | 康希诺生物 03月11日卖空量成交5800股,卖空比例为1.68%
康希诺生物03月11日主力净流出62.0万元 散户资金买入
市场透视 · 03-11
康希诺生物03月11日主力净流出62.0万元 散户资金买入
全国政协委员、康希诺生物首席科学官朱涛:医防融合 进一步强化青少年及成人疫苗接种工作
每日经济新闻 · 03-10
全国政协委员、康希诺生物首席科学官朱涛:医防融合 进一步强化青少年及成人疫苗接种工作
港股异动 | 康希诺生物(06185)涨超5% 生产基地获得马来西亚PIC/S GMP认证
智通财经 · 03-06
港股异动 | 康希诺生物(06185)涨超5% 生产基地获得马来西亚PIC/S GMP认证
康希诺生物(06185)获得PIC/S GMP认证
智通财经 · 03-05
康希诺生物(06185)获得PIC/S GMP认证
每日卖空追踪 | 康希诺生物 03月05日卖空量成交3.2万股,卖空比例为4.32%
市场透视 · 03-05
每日卖空追踪 | 康希诺生物 03月05日卖空量成交3.2万股,卖空比例为4.32%
每日卖空追踪 | 康希诺生物 03月04日卖空量成交6.74万股,卖空比例为12.64%
市场透视 · 03-04
每日卖空追踪 | 康希诺生物 03月04日卖空量成交6.74万股,卖空比例为12.64%
康希诺生物(06185.HK,688185.SH)2月股份变动月报表:股本维持稳定
公告速递 · 03-02
康希诺生物(06185.HK,688185.SH)2月股份变动月报表:股本维持稳定
每日卖空追踪 | 康希诺生物 03月02日卖空量成交7.96万股,卖空比例为7.2%
市场透视 · 03-02
每日卖空追踪 | 康希诺生物 03月02日卖空量成交7.96万股,卖空比例为7.2%
康希诺生物03月02日遭主力抛售63.7万元
市场透视 · 03-02
康希诺生物03月02日遭主力抛售63.7万元
康希诺生物(06185)发布2025年度业绩快报 归母净利润2787.27万元,同比扭亏为盈
智通财经 · 02-26
康希诺生物(06185)发布2025年度业绩快报 归母净利润2787.27万元,同比扭亏为盈
每日卖空追踪 | 康希诺生物 02月26日卖空量成交1.7万股,卖空比例为1.9%
市场透视 · 02-26
每日卖空追踪 | 康希诺生物 02月26日卖空量成交1.7万股,卖空比例为1.9%
康希诺生物(06185):曼海欣®获得《药品补充申请批准通知书》
智通财经 · 02-24
康希诺生物(06185):曼海欣®获得《药品补充申请批准通知书》
康希诺:ACYW135群脑膜炎球菌多糖结合疫苗适用人群年龄范围扩大
格隆汇APP · 02-24
康希诺:ACYW135群脑膜炎球菌多糖结合疫苗适用人群年龄范围扩大
每日卖空追踪 | 康希诺生物 02月23日卖空量成交6600股,卖空比例为4.28%
市场透视 · 02-23
每日卖空追踪 | 康希诺生物 02月23日卖空量成交6600股,卖空比例为4.28%
每日卖空追踪 | 康希诺生物 02月20日卖空量成交1.1万股,卖空比例为5.77%
市场透视 · 02-20
每日卖空追踪 | 康希诺生物 02月20日卖空量成交1.1万股,卖空比例为5.77%
加载更多
公司概况
公司名称:
康希诺生物
所属市场:
SEHK
上市日期:
--
主营业务:
康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。
发行价格:
--
{"stockData":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":33.04,"timestamp":1775117301007,"preClose":33.82,"halted":0,"volume":1052800,"delay":0,"changeRate":-0.023063276167947993,"floatShares":132670900,"shares":247043801,"eps":0.11,"marketStatus":"清明节翌日休市","change":-0.78,"latestTime":"04-02 16:08:21","open":33.54,"high":33.66,"low":32.42,"amount":34610560,"amplitude":0.036665,"askPrice":33.12,"askSize":1400,"bidPrice":33.04,"bidSize":800,"shortable":3,"etf":0,"ttmEps":0.122409,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":7,"adr":0,"listingDate":1553702400000,"exchange":"SEHK","adjPreClose":33.82,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":1.096415404711719,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":67,"timestamp":1775199600000,"preClose":68.38,"halted":0,"volume":1786600,"delay":0,"premium":"-56.67"}},"requestUrl":"/m/hq/s/06185","defaultTab":"news","newsList":[{"id":"1192168799","title":"康希诺生物更新3月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1192168799","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192168799?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:36","pubTimestamp":1775118981,"startTime":"0","endTime":"0","summary":"2026年4月2日,康希诺生物发布截至2026年3月31日的股份变动月报表。公告显示,公司本月未有新增发行、回购或注销股份,整体股本结构保持不变。公司全称为康希諾生物股份公司。报告期内,法定/注册股本总额为人民币247,043,801元。其中,H股法定/注册股份数为132,670,900股,A股法定/注册股份数为114,372,901股,两类股份数量均与上月一致,且已发行股本均无变化。截至3月末,公司并无任何股份购回活动或注销事宜,已发行股本总数保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142883845","title":"异动解读 | 康希诺生物盘中大涨9.68%,业绩扭亏为盈及流脑疫苗收入增长提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1142883845","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142883845?lang=zh_cn&edition=full","pubTime":"2026-04-01 12:50","pubTimestamp":1775019015,"startTime":"0","endTime":"0","summary":"康希诺生物(06185)今日盘中大幅上涨9.68%,引起了市场的广泛关注。消息面上,公司发布了年度业绩报告,显示全年实现营业收入10.59亿元人民币,同比增长28.43%;并实现扭亏为盈,公司拥有人应占溢利为2787.30万元人民币。此外,公司还公布了未来三年的股东分红回报规划,明确了现金分红优先的原则,增强了投资者信心。业绩增长主要得益于其核心产品——中国首款四价流脑结合疫苗“曼海欣”的收入持续增长。公司通过坚持创新与商业化并重的发展战略,深入推进降本增效,优化产销协同,从而持续提升了经营效率。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624956661","title":"港股异动 | 康希诺生物(06185)午前涨近10% 流脑疫苗收入持续增长 全年纯利实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2624956661","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624956661?lang=zh_cn&edition=full","pubTime":"2026-04-01 11:56","pubTimestamp":1775015783,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康希诺生物(06185)午前涨近10%,截至发稿,涨9.49%,报34.16港元,成交额2834.76万港元。消息方面,康希诺生物发布年度业绩。全年实现营业收入10.59亿人民币元,同比增长28.43%;本公司拥有人应占溢利2787.30万人民币元 ,同比扭亏为盈。此外,公司发布未来三年股东分红回报规划,明确现金分红优先原则。公告显示,报告期内,业绩增长主要得益于公司核心产品中国首款四价流脑结合疫苗曼海欣的收入持续增长;公司通过持续践行以创新为核心、以商业化为重点的发展战略,深入推进降本增效,同时优化了产销协同,经营效率持续提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","VXUS","159646","BK4585","BK1191","06185","BK1161","BK4588","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623478333","title":"康希诺生物(06185)公布2025年业绩 实现收入约10.59亿元 同比增长28.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623478333","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623478333?lang=zh_cn&edition=full","pubTime":"2026-03-31 00:07","pubTimestamp":1774886865,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康希诺生物 公布2025年业绩,收入约10.59亿元,同比增长28.43%;年内利润2787.3万元,同比扭亏为盈;每股盈利0.11元。自2022年推出四价流脑结合疫苗曼海欣和二价流脑结合疫苗美奈喜以来,两款疫苗为预防婴幼儿流脑疾病提供了更为高效、优质的疫苗选择。2025年,随着流脑疫苗产品的推广和市场导入,两款流脑结合疫苗实现销售收入约9.677亿元,同比增长21.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物(06185)公布2025年业绩 实现收入约10.59亿元 同比增长28.43%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","BK1515","BK1191","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618909611","title":"每日卖空追踪 | 康希诺生物 03月11日卖空量成交5800股,卖空比例为1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618909611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618909611?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217837,"startTime":"0","endTime":"0","summary":"康希诺生物北京时间03月11日,跌2.29%,卖空量成交5800股,较上一交易日减少88.63%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163547a6b796a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163547a6b796a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1191","06185","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618090966","title":"康希诺生物03月11日主力净流出62.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618090966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618090966?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:15","pubTimestamp":1773216948,"startTime":"0","endTime":"0","summary":"03月11日, 康希诺生物股价跌2.29%,报收34.06元,成交金额1181.7万元,换手率0.26%,振幅3.96%,量比0.50。康希诺生物今日主力资金净流出62.0万元,上一交易日主力净流入52.7万元。该股近5个交易日上涨7.58%,主力资金累计净流入203.6万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出82.2万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161931a460aa83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161931a460aa83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","06185","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618512929","title":"全国政协委员、康希诺生物首席科学官朱涛:医防融合 进一步强化青少年及成人疫苗接种工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2618512929","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618512929?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:45","pubTimestamp":1773153943,"startTime":"0","endTime":"0","summary":"构建并完善全生命周期免疫规划体系。以“十四五”收官总结与“十五五”规划谋划为关键契机,推动免疫规划从“婴幼儿重点覆盖”向“全人群动态保障”转型,建立基于疾病负担监测数据的青少年及成人疫苗接种动态评估机制,按疾病危害程度、人群感染风险适时扩大免疫规划疫苗品类与覆盖年龄范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603103667812167.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603103667812167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1191","BK1574","BK1161","06185","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617507452","title":"港股异动 | 康希诺生物(06185)涨超5% 生产基地获得马来西亚PIC/S GMP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617507452","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617507452?lang=zh_cn&edition=full","pubTime":"2026-03-06 15:00","pubTimestamp":1772780457,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康希诺生物涨超5%,截至发稿,涨5.53%,报33.98港元,成交额2325.1万港元。消息面上,康希诺生物昨晚公布,公司自主研发的ACYW135群脑膜炎球菌多糖结合疫苗曼海欣和13价肺炎球菌多糖结合疫苗优佩欣生产基地通过了马来西亚药监局PIC/S GMP符合性检查,并于近日获得NPRA颁发的GMP证书。公司指,此次通过PIC/S GMP认证,标志着康希诺生物的生产和质量管理体系已达到国际药品检查合作组织GMP标准要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","VXUS","06185","BK1161","BK1191","BK4588","BK1574","BK4585","VT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617917512","title":"康希诺生物(06185)获得PIC/S GMP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617917512","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617917512?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:57","pubTimestamp":1772701020,"startTime":"0","endTime":"0","summary":"PIC/S为国际药品检查、认证的权威机构,由数十个国家的药品监管机构组成,以统一标准对人用和兽用药品的GMP实施检查、认证,GMP符合性检查是药品注册上市的必要条件之一。在自愿的基础上,PIC/S成员国及参与机构之间执行 GMP符合性检查互认。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","06185","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617521388","title":"每日卖空追踪 | 康希诺生物 03月05日卖空量成交3.2万股,卖空比例为4.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617521388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617521388?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699437,"startTime":"0","endTime":"0","summary":"康希诺生物北京时间03月05日,涨1.71%,卖空量成交3.2万股,较上一交易日减少71.33%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163522a44ef988&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163522a44ef988&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1191","BK1161","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616555835","title":"每日卖空追踪 | 康希诺生物 03月04日卖空量成交6.74万股,卖空比例为12.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616555835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616555835?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613036,"startTime":"0","endTime":"0","summary":"康希诺生物北京时间03月04日,跌0.75%,卖空量成交6.74万股,较上一交易日减少37.71%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163543a6a15194&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163543a6a15194&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","BK1191","06185","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174065368","title":"康希诺生物(06185.HK,688185.SH)2月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1174065368","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174065368?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:37","pubTimestamp":1772440651,"startTime":"0","endTime":"0","summary":"康希诺生物股份公司于2026年3月2日发布截至2026年2月28日的月度股份变动报告。公告显示,公司注册股本为人民币247,043,801元。其中,H股132,670,900股、A股114,372,901股,较上月底均无变化。公司已披露的2025年核心管理层H股购股权计划与2025年A股限制性股票激励计划在本月均无行权、失效或其他变动。截至2月末,公司股本结构保持稳定。公司声明将继续遵守香港联交所《上市规则》及相关法律法规要求。本次公告由联席公司秘书崔进签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616380448","title":"每日卖空追踪 | 康希诺生物 03月02日卖空量成交7.96万股,卖空比例为7.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616380448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616380448?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440240,"startTime":"0","endTime":"0","summary":"康希诺生物北京时间03月02日,跌5.75%,卖空量成交7.96万股,较上一交易日增加128.74%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163623a4415375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163623a4415375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1574","BK1161","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616380444","title":"康希诺生物03月02日遭主力抛售63.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616380444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616380444?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:15","pubTimestamp":1772439321,"startTime":"0","endTime":"0","summary":"03月02日, 康希诺生物股价跌5.75%,报收33.44元,成交金额3760.5万元,换手率0.83%,振幅5.41%,量比1.43。康希诺生物今日主力资金净流出63.7万元,连续3日净流出,上一交易日主力净流出158.4万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为75.00%,平均跌幅为1.76%。该股近5个交易日下跌1.59%,主力资金累计净流出298.6万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1330.1万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161625a44137d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161625a44137d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK1191","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614158240","title":"康希诺生物(06185)发布2025年度业绩快报 归母净利润2787.27万元,同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2614158240","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614158240?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:49","pubTimestamp":1772095763,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康希诺生物 发布2025年度业绩快报,营业总收入10.68亿元,同比增长26.18%;归属于母公司所有者的净利润2787.27万元,同比扭亏为盈;基本每股收益0.11元。本集团整体盈利能力显着提升,成功于报告期实现归属于母公司所有者的净利润为正。报告期末,本公司股本约为2.47亿股,较报告期初减少约为41万股,主要因本公司注销以前年度回购的部分A股股份所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物(06185)发布2025年度业绩快报 归母净利润2787.27万元,同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614025974","title":"每日卖空追踪 | 康希诺生物 02月26日卖空量成交1.7万股,卖空比例为1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614025974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614025974?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:30","pubTimestamp":1772094637,"startTime":"0","endTime":"0","summary":"康希诺生物北京时间02月26日,涨0.24%,卖空量成交1.7万股,较上一交易日增加93.18%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163547a4cab6fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163547a4cab6fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","06185","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613078795","title":"康希诺生物(06185):曼海欣®获得《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2613078795","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613078795?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:42","pubTimestamp":1771922526,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康希诺生物 发布公告,公司已获得国家药监局出具的《药品补充申请批准通知书》,根据该通知书,国家药监局已批准公司的ACYW135群脑膜炎球菌多糖结合疫苗的适用人群年龄范围由“3月龄到3周岁儿童”扩大至“3月龄到6周岁儿童”的补充申请。曼海欣凭借其创新优势,展现出强劲的市场表现力,实现了市场占有率的不断攀升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物(06185):曼海欣®获得《药品补充申请批准通知书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","BK1574","06185","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614065773","title":"康希诺:ACYW135群脑膜炎球菌多糖结合疫苗适用人群年龄范围扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2614065773","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614065773?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:03","pubTimestamp":1771920180,"startTime":"0","endTime":"0","summary":"格隆汇2月24日丨康希诺(688185.SH)公告称,公司产品ACYW135群脑膜炎球菌多糖结合疫苗(CRM197载体)适用人群年龄范围由“3月龄~3周岁(47月龄)儿童”扩大至“3月龄~6周岁(83月龄)儿童”。该疫苗为我国首个脑膜炎球菌四价结合疫苗产品,其适用人群年龄范围的扩大预计将对公司业绩产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224170013a4c250dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224170013a4c250dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1191","06185","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613789569","title":"每日卖空追踪 | 康希诺生物 02月23日卖空量成交6600股,卖空比例为4.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613789569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613789569?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835437,"startTime":"0","endTime":"0","summary":"康希诺生物北京时间02月23日,涨1.55%,卖空量成交6600股,较上一交易日减少58.75%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163515a4be7e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163515a4be7e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06185","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613421416","title":"每日卖空追踪 | 康希诺生物 02月20日卖空量成交1.1万股,卖空比例为5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613421416","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613421416?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576235,"startTime":"0","endTime":"0","summary":"康希诺生物北京时间02月20日,涨0.36%,卖空量成交1.1万股,较上一交易日增加111.54%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163518a70cd10f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163518a70cd10f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK1191","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cansinotech.com","stockEarnings":[{"period":"1week","weight":0.0762},{"period":"1month","weight":0.0357},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.3658},{"period":"1year","weight":-0.0573},{"period":"ytd","weight":-0.0538}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.030578},{"month":2,"riseRate":0.857143,"avgChangeRate":0.172684},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.060436},{"month":4,"riseRate":0.75,"avgChangeRate":0.064491},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.041855},{"month":6,"riseRate":0.571429,"avgChangeRate":0.037423},{"month":7,"riseRate":0.571429,"avgChangeRate":0.056212},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.143307},{"month":9,"riseRate":0.714286,"avgChangeRate":0.068326},{"month":10,"riseRate":0.428571,"avgChangeRate":0.059174},{"month":11,"riseRate":0.571429,"avgChangeRate":0.088604},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.035813}],"exchange":"SEHK","name":"康希诺生物","nameEN":"CANSINOBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺生物,06185,康希诺生物股票,康希诺生物股票老虎,康希诺生物股票老虎国际,康希诺生物行情,康希诺生物股票行情,康希诺生物股价,康希诺生物股市,康希诺生物股票价格,康希诺生物股票交易,康希诺生物股票购买,康希诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}